VanEck Biotech ETF
ETFYour view on BBH
VanEck Biotech ETF
ETFVanEckSentiment
AUM (USD)
$458.69M
Expense Ratio
0.35%
Holdings
25
Sentiment
Overview for VanEck Biotech ETF
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- VanEck
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- December 20, 2011
- Domicile
- US
About this fund
VanEck Biotech ETF (BBH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index (MVBBHTR), which is intended to track the overall performance of companies involved in the development and producti…
BBH Stock Price
Key Facts
EquityExpense Ratio
0.35%
AUM
$458.69M
Fund Details
Expense Ratio
0.35%
Assets Under Management
$458.69M
NAV
$228.60 USD
Holdings
25
Average Volume
6.8K
Inception Date
December 20, 2011
Asset Class
Equity
Fund Issuer
VanEck
Domicile
US
ISIN
US92189F7261
CUSIP
92189F726
NAV Currency
USD
Expense Ratio
0.35%
Assets Under Management
$458.69M
NAV
$228.60 USD
Holdings
25
Average Volume
6.8K
Inception Date
December 20, 2011
Asset Class
Equity
Fund Issuer
VanEck
Domicile
US
ISIN
US92189F7261
CUSIP
92189F726
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.